Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Q1 2006/07 Earnings Presentation
13 slides from Coloplast A/s Class B's earnings presentation, Feb 8, 2007
Slide 1: Coloplast's Financial Statement Q1 2006/07
1 Coloplast’s Financial Statement Q1 2006/07 Conference call presentation 8 February 2007
Slide 2: Financial highlights Q1 2006/07
8 February 2007 2 Financial highlights Q1 2006/07 • Coloplast generated revenue of DKK 2,048m compared with DKK 1,646m for the same period last year. This represents an increase of 26% in local currencies, 19% of which derives from the acquired urology business • Exchange-rate changes reduced the va
Slide 3: Income statement Q1 2006/07
8 February 2007 3 Income statement Q1 2006/07 DKKm Q1 06/07 Q1 05/06 Index Net revenue 2,048 1,646 124 Gross profit 1,220 1,028 119 - Gross profit margin 60% 62% EBITDA 405 368 110 - EBITDA margin 20% 22% Net operating profit (EBIT) 260 275 95 - Profit margin 13% 17% Profit before tax 202 236 86 Tax
Slide 4: Balance sheet, cash flows and key ratios Q1 2006/07
8 February 2007 4 Balance sheet, cash flows and key ratios Q1 2006/07 DKKm Q1 06/07 Q1 05/06 Invested capital 8,208 5,565 Net interest bearing debt 3,306 1,136 Equity, ultimo 2,777 2,417 Investments in tangible assets 134 97 Free cash flow -6 -1 - Cash flow from operations 106 104 - Cash flow from i
Slide 5: Impact from acquisition of urology business
8 February 2007 5 Impact from acquisition of urology business Impacts on profitability in Q1 2006/07 Estimated full year financial impacts related to acquisition of urology buisness from acquisition and restructurings DKKm Q1 06/07 DKKm FY 06/07 Operating profit, underlying 344 Integration costs -13
Slide 6: Revenue development - business areas
8 February 2007 6 Revenue development - business areas Growth Growth Growth Revenue Growth in local currencies Q1 06/07 Q4 05/06 Q1 05/06 Q1 06/07 Ostomy Care 6% 6% 7% 738 Urology & Continence Care 68% 75% - 754 - Excl. urology business 12% 6% 15% - Wound & Skin Care 6% 3% 8% 303 Breast Care -1% 7%
Slide 7: Revenue development - geography
8 February 2007 7 Revenue development - geography Growth Organic Growth Revenue Growth in local currencies Q1 06/07 Q1 06/07 Q1 05/06 Q1 06/07 Europe 17% 6% 7% 1,601 The Americas 106% 6% 8% 317 Rest of World 28% 13% 15% 130 Group net revenue 26% 7% 8% 2,048 • Revenue in the US doubled due 6% to the
Slide 8: Highlights from business areas
8 February 2007 8 Highlights from business areas • Ostomy Care - SenSura is being launched in new markets. HSC established as independent business unit. • Urology & Continence Care - Main growth contribution from sale of urological disposables and intermittent catheters. Integration progressing as p
Slide 9: Urology & Continence Care - integration
8 February 2007 9 Urology & Continence Care - integration Integration process on track • Establish new headquarters in the US • Discontinue manufacturing in Lancing, UK • Integrate sales organisations in all countries • Optimise procurement • Combine and expand R&D • Reach one IT platform and report
Slide 10: Management issues
8 February 2007 10 Management issues • Share buyback programme initiated worth around DKK 1 billion • Updated Global Operations strategy launched in October 2006 • In November 2006, the British health authorities issued two consultation papers addressing reimbursement pricing of stoma and incontinen
Slide 11: Expectations and long-term targets
8 February 2007 11 Expectations and long-term targets 2006/07 • Sales growth of around 22% in local currencies of which around 9%-points will be organic growth • EBITDA margin of 18-19% and profit margin (EBIT) of 12-13% • Investments in tangible assets of DKK 700m • Corporate tax rate of 30% • Net
Slide 12: Analysts' estimates Q1 2006/07
8 February 2007 12 Analysts’ estimates Q1 2006/07 Net EBITii DKKm revenue EBITi margini PBTi High 2,193 363 12.0% 208 Mean 2,108 227 10.8% 178 Low 2,063 191 9.0% 133 Coloplast actual 2,048 260* 12.7% 202 Index to mean 97 115 118 113 * As reported, includes integration costs and depreciations of acqu
Slide 13: 8 February 2007
aT MMS | MNES ee wp Coloplast